RAP 6.90% 5.4¢ resapp health limited

Agree, RAP have a strategy to get around the probable benefit...

  1. 10,357 Posts.
    lightbulb Created with Sketch. 658
    Agree, RAP have a strategy to get around the probable benefit outweigh risk and after 4 months more than usual for the submission review with the FDA and them requesting more human factor studies, the US is clearly not ready for ResAppDx to be regulatory approved as a diagnostic tool but triage for respiratory tract infection is a viable path. This show how behind even the US is at adopting smart phone as a diagnostic medical device compared to Europe, that's why they are considered the leaders in telehealth worldwide.
    Last edited by AlCp: 23/02/21
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
(20min delay)
Mkt cap ! $40.93M
Open High Low Value Volume
5.8¢ 5.8¢ 5.4¢ $154.2K 2.798M

Buyers (Bids)

No. Vol. Price($)
1 345370 5.4¢

Sellers (Offers)

Price($) Vol. No.
5.8¢ 266796 1
View Market Depth
Last trade - 16.10pm 05/03/2021 (20 minute delay) ?
-0.004 ( 1.82 %)
Open High Low Volume
5.5¢ 5.7¢ 5.3¢ 1059159
Last updated 15.45pm 05/03/2021 (live) ?
RAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.